The microbiome and chronic rhinosinusitis

Rahuram Sivasubramaniam, Richard Douglas, Rahuram Sivasubramaniam, Richard Douglas

Abstract

Chronic rhinosinusitis (CRS) is a multifactorial condition in which the microbiota plays a pathogenic role. The nature of the interaction between the microbiota and the local immune system is very complex and has not been fully elucidated. Recent improvements in the microbiological techniques have greatly advanced our understanding of the complex nature of this interaction. This paper summarizes the current state of the rapidly evolving research on this subject. Defining the nature of the role of the microbiota in CRS is important because of the associated therapeutic implications.

Keywords: Bacteriology; Inflammation; Microbiome; Pathogenesis; Polyposis; Sinusitis.

References

    1. Luckey T.D. Introduction to intestinal micro ecology. Am J Clin Nutr. 1972;25:1292–1294.
    1. Bäckhed F., Ley R.E., Sonnenburg J.L., Peterson D.A., Gordon J.I. Host-bacterial mutualism in the human intestine. Science. 2005;307:1915–1920.
    1. Man W.H., de Steenhuijsen Piters W.A., Bogaert D. The microbiota of the respiratory tract: gatekeeper to respiratory health. Nat Rev Microbiol. 2017;15:259–270.
    1. Eidi S., Kamali S.A., Hajari Z. Nasal and indoors fungal contamination in healthy subjects. Health Scope. 2016;5
    1. Charlson E.S., Diamond J.M., Bittinger K. Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant. Am J Respir Crit Care Med. 2012;186:536–545.
    1. van den Bergh M.R., Biesbroek G., Rossen J.W. Associations between pathogens in the upper respiratory tract of young children: interplay between viruses and bacteria. PLoS One. 2012;7
    1. Bäumler A.J., Sperandio V. Interactions between the microbiota and pathogenic bacteria in the gut. Nature. 2016;535:85–93.
    1. Hoggard M., Biswas K., Zoing M., Wagner M.B., Taylor M.W., Douglas R.G. Evidence of microbiota dysbiosis in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2017;7:230–239.
    1. Choi E.B., Hong S.W., Kim D.K. Decreased diversity of nasal microbiota and their secreted extracellular vesicles in patients with chronic rhinosinusitis based on a metagenomic analysis. Allergy. 2014;69:517–526.
    1. Ramakrishnan V.R., Feazel L.M., Gitomer S.A., Ir D., Robertson C.E., Frank D.N. The microbiome of the middle meatus in healthy adults. PLoS One. 2013;8
    1. Wagner M.B., Waite D.W., Hoggard M., Douglas R.G., Taylor M.W., Biswas K. Bacterial community collapse: a meta-analysis of the sinonasal microbiota in chronic rhinosinusitis. Environ Microbiol. 2017;19:381–392.
    1. Biswas K., Hoggard M., Jain R., Taylor M.W., Douglas R.G. The nasal microbiota in health and disease: variation within and between subjects. Front Microbiol. 2015;9:134.
    1. Goodrich J.K., Waters J.L., Poole A.C. Human genetics shape the gut microbiome. Cell. 2014;159:789–799.
    1. Biesbroek G., Tsivtsivadze E., Sanders E.A. Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children. Am J Respir Crit Care Med. 2014;190:1283–1292.
    1. Bomar L., Brugger S.D., Yost B.H., Davies S.S., Lemon K.P. Corynebacterium accolens releases antipneumococcal free fatty acids from human nostril and skin surface triacylglycerols. MBio. 2016;7
    1. Sousa A.M., Pereira M.O. A prospect of current microbial diagnosis methods. In: Mendez-Vilas, editor. vol. 3. Formatex; Badajoz: 2013. pp. 1429–1438. (Microbial Pathogens and Strategies for Combating Them: Science, Technology and Education).
    1. Malik S., Beer M., Megharaj M., Naidu R. The use of molecular techniques to characterize the microbial communities in contaminated soil and water. Environ Int. 2008;34:265–276.
    1. Weile J., Knabbe C. Current applications and future trends of molecular diagnostics in clinical bacteriology. Anal Bioanal Chem. 2009;394:731–742.
    1. McLoughlin K.S. Microarrays for pathogen detection and analysis. Brief Funct Genomics. 2011;10:342–353.
    1. Kuczynski J., Lauber C.L., Walters W.A. Experimental and analytical tools for studying the human microbiome. Nat Rev Genet. 2011;13:47–58.
    1. DeConde A.S., Soler Z.M. Chronic rhinosinusitis: epidemiology and burden of disease. Am J Rhinol Allergy. 2016;30:134–139.
    1. Baroody F.M., Mucha S.M., Detineo M., Naclerio R.M. Nasal challenge with allergen leads to maxillary sinus inflammation. J Allergy Clin Immunol. 2008;121 1126–1132.e7.
    1. Fokkens W.J., Lund V.J., Mullol J. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl. 2012;23 3 p preceding table of contents, 1–298.
    1. Platt M.P., Soler Z., Metson R., Stankovic K.M. Pathways analysis of molecular markers in chronic sinusitis with polyps. Otolaryngol Head Neck Surg. 2011;144:802–808.
    1. Lam K., Schleimer R., Kern R.C. The etiology and pathogenesis of chronic rhinosinusitis: a review of current hypotheses. Curr Allergy Asthma Rep. 2015;15:41.
    1. Bachert C., Zhang N., Patou J., van Zele T., Gevaert P. Role of staphylococcal superantigens in upper airway disease. Curr Opin Allergy Clin Immunol. 2008;8:34–38.
    1. Psaltis A.J., Ha K.R., Beule A.G., Tan L.W., Wormald P.J. Confocal scanning laser microscopy evidence of biofilms in patients with chronic rhinosinusitis. Laryngoscope. 2007;117:1302–1306.
    1. Wagner M.B., Waite D.W., Hoggard M., Taylor M.W., Biswas K., Douglas R.G. Moving beyond descriptions of diversity: clinical and research implications of bacterial imbalance in chronic rhinosinusitis. Rhinology. 2017;55:291–297.
    1. Nadel D.M., Lanza D.C., Kennedy D.W. Endoscopically guided sinus cultures in normal subjects. Am J Rhinol. 1999;13:87–90.
    1. Abou-Hamad W., Matar N., Elias M. Bacterial flora in normal adult maxillary sinuses. Am J Rhinol Allergy. 2009;23:261–263.
    1. Jain R., Waldvogel-Thurlow S., Darveau R., Douglas R. Differences in the paranasal sinuses between germ-free and pathogen-free mice. Int Forum Allergy Rhinol. 2016;6:631–637.
    1. Yatsunenko T., Rey F.E., Manary M.J. Human gut microbiome viewed across age and geography. Nature. 2012;486:222–227.
    1. Lal D., Keim P., Delisle J. Mapping and comparing bacterial microbiota in the sinonasal cavity of healthy, allergic rhinitis, and chronic rhinosinusitis subjects. Int Forum Allergy Rhinol. 2017;7:561–569.
    1. Human Microbiome Project Consortium Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207–214.
    1. Kaspar U., Kriegeskorte A., Schubert T. The culturome of the human nose habitats reveals individual bacterial fingerprint patterns. Environ Microbiol. 2016;18:2130–2142.
    1. Wos-Oxley M.L., Chaves-Moreno D., Jáuregui R. Exploring the bacterial assemblages along the human nasal passage. Environ Microbiol. 2016;18:2259–2271.
    1. Schwartz J.S., Peres A.G., Mfuna E.L., Cousineau B., Madrenas J., Desrosiers M. Topical probiotics as a therapeutic alternative for chronic rhinosinusitis: a preclinical proof of concept. Am J Rhinol Allergy. 2016;30:202–205.
    1. Psaltis A.J., Wormald P.J. Therapy of sinonasal microbiome in CRS: a critical approach. Curr Allergy Asthma Rep. 2017;17:59.
    1. Araujo E., Palombini B.C., Cantarelli V., Pereira A., Mariante A. Microbiology of middle meatus in chronic rhinosinusitis. Am J Rhinol. 2003;17:9–15.
    1. Hauser L.J., Feazel L.M., Ir D. Sinus culture poorly predicts resident microbiota. Int Forum Allergy Rhinol. 2015;5:3–9.
    1. Merino L.A., Ronconi M.C., Hreñuk G.E., de Pepe M.G. Bacteriologic findings in patients with chronic sinusitis. Ear Nose Throat J. 2003;82 798–800, 803–804, 806.
    1. Cleland E.J., Bassiouni A., Wormald P.J. The bacteriology of chronic rhinosinusitis and the pre-eminence of Staphylococcus aureus in revision patients. Int Forum Allergy Rhinol. 2013;3:642–646.
    1. Mahdavinia M., Keshavarzian A., Tobin M.C., Landay A.L., Schleimer R.P. A comprehensive review of the nasal microbiome in chronic rhinosinusitis (CRS) Clin Exp Allergy. 2016;46:21–41.
    1. Feazel L.M., Robertson C.E., Ramakrishnan V.R., Frank D.N. Microbiome complexity and Staphylococcus aureus in chronic rhinosinusitis. Laryngoscope. 2012;122:467–472.
    1. Abreu N.A., Nagalingam N.A., Song Y. Sinus microbiome diversity depletion and Corynebacterium tuberculostearicum enrichment mediates rhinosinusitis. Sci Transl Med. 2012;4 151ra124.
    1. Cardinale B.J., Duffy J.E., Gonzalez A. Biodiversity loss and its impact on humanity. Nature. 2012;486:59–67.
    1. Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318–1322.
    1. Boase S., Valentine R., Singhal D., Tan L.W., Wormald P.J. A sheep model to investigate the role of fungal biofilms in sinusitis: fungal and bacterial synergy. Int Forum Allergy Rhinol. 2011;1:340–347.
    1. Foreman A., Boase S., Psaltis A., Wormald P.J. Role of bacterial and fungal biofilms in chronic rhinosinusitis. Curr Allergy Asthma Rep. 2012;12:127–135.
    1. Ferguson B.J., Stolz D.B. Demonstration of biofilm in human bacterial chronic rhinosinusitis. Am J Rhinol. 2005;19:452–457.
    1. Sanclement J.A., Webster P., Thomas J., Ramadan H.H. Bacterial biofilms in surgical specimens of patients with chronic rhinosinusitis. Laryngoscope. 2005;115:578–582.
    1. Boase S., Foreman A., Cleland E. The microbiome of chronic rhinosinusitis: culture, molecular diagnostics and biofilm detection. BMC Infect Dis. 2013;13:210.
    1. Wood A.J., Fraser J., Swift S., Amirapu S., Douglas R.G. Are biofilms associated with an inflammatory response in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2011;1:335–339.
    1. Galli J., Calò L., Ardito F. Damage to ciliated epithelium in chronic rhinosinusitis: what is the role of bacterial biofilms. Ann Otol Rhinol Laryngol. 2008;117:902–908.
    1. Plouin-Gaudon I., Clement S., Huggler E. Intracellular residency is frequently associated with recurrent Staphylococcus aureus rhinosinusitis. Rhinology. 2006;44:249–254.
    1. Wood A.J., Fraser J.D., Swift S., Patterson-Emanuelson E.A., Amirapu S., Douglas R.G. Intramucosal bacterial microcolonies exist in chronic rhinosinusitis without inducing a local immune response. Am J Rhinol Allergy. 2012;26:265–270.
    1. Liu C.M., Soldanova K., Nordstrom L. Medical therapy reduces microbiota diversity and evenness in surgically recalcitrant chronic rhinosinusitis. Int Forum Allergy Rhinol. 2013;3:775–781.
    1. Liu C.M., Kohanski M.A., Mendiola M. Impact of saline irrigation and topical corticosteroids on the postsurgical sinonasal microbiota. Int Forum Allergy Rhinol. 2015;5:185–190.
    1. Korpela K., Salonen A., Virta L.J. Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat Commun. 2016;7:10410.
    1. Maxfield A.Z., Korkmaz H., Gregorio L.L. General antibiotic exposure is associated with increased risk of developing chronic rhinosinusitis. Laryngoscope. 2017;127:296–302.
    1. Cleland E.J., Bassiouni A., Vreugde S., Wormald P.J. The bacterial microbiome in chronic rhinosinusitis: richness, diversity, postoperative changes, and patient outcomes. Am J Rhinol Allergy. 2016;30:37–43.
    1. Jain R., Hoggard M., Biswas K., Zoing M., Jiang Y., Douglas R. Changes in the bacterial microbiome of patients with chronic rhinosinusitis after endoscopic sinus surgery. Int Forum Allergy Rhinol. 2017;7:7–15.
    1. Bendouah Z., Barbeau J., Hamad W.A., Desrosiers M. Biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa is associated with an unfavorable evolution after surgery for chronic sinusitis and nasal polyposis. Otolaryngol Head Neck Surg. 2006;134:991–996.
    1. Cleland E.J., Drilling A., Bassiouni A., James C., Vreugde S., Wormald P.J. Probiotic manipulation of the chronic rhinosinusitis microbiome. Int Forum Allergy Rhinol. 2014;4:309–314.
    1. Habermann W., Zimmermann K., Skarabis H., Kunze R., Rusch V. Reduction of acute recurrence in patients with chronic recurrent hypertrophic sinusitis by treatment with a bacterial immunostimulant (Enterococcus faecalis Bacteriae of human origin) Arzneimittelforschung. 2002;52:622–627.
    1. Mukerji S.S., Pynnonen M.A., Kim H.M., Singer A., Tabor M., Terrell J.E. Probiotics as adjunctive treatment for chronic rhinosinusitis: a randomized controlled trial. Otolaryngol Head Neck Surg. 2009;140:202–208.
    1. Wylie K.M., Mihindukulasuriya K.A., Zhou Y., Sodergren E., Storch G.A., Weinstock G.M. Metagenomic analysis of double-stranded DNA viruses in healthy adults. BMC Biol. 2014;12:71.
    1. Ramadan H.H., Farr R.W., Wetmore S.J. Adenovirus and respiratory syncytial virus in chronic sinusitis using polymerase chain reaction. Laryngoscope. 1997;107:923–925.
    1. Cho G.S., Moon B.J., Lee B.J. High rates of detection of respiratory viruses in the nasal washes and mucosae of patients with chronic rhinosinusitis. J Clin Microbiol. 2013;51:979–984.
    1. Wood A.J., Antoszewska H., Fraser J., Douglas R.G. Is chronic rhinosinusitis caused by persistent respiratory virus infection. Int Forum Allergy Rhinol. 2011;1:95–100.
    1. Liao B., Hu C.Y., Liu T., Liu Z. Respiratory viral infection in the chronic persistent phase of chronic rhinosinusitis. Laryngoscope. 2014;124:832–837.
    1. Cleland E.J., Bassiouni A., Bassioni A. The fungal microbiome in chronic rhinosinusitis: richness, diversity, postoperative changes and patient outcomes. Int Forum Allergy Rhinol. 2014;4:259–265.
    1. Aurora R., Chatterjee D., Hentzleman J., Prasad G., Sindwani R., Sanford T. Contrasting the microbiomes from healthy volunteers and patients with chronic rhinosinusitis. JAMA Otolaryngol Head Neck Surg. 2013;139:1328–1338.
    1. Zhao Y.C., Bassiouni A., Tanjararak K., Vreugde S., Wormald P.J., Psaltis A.J. Role of fungi in chronic rhinosinusitis through ITS sequencing. Laryngoscope. 2018;128:16–22.
    1. Gelber J.T., Cope E.K., Goldberg A.N., Pletcher S.D. Evaluation of Malassezia and common fungal pathogens in subtypes of chronic rhinosinusitis. Int Forum Allergy Rhinol. 2016;6:950–955.
    1. Hogan D.A., Kolter R. Pseudomonas-Candida interactions: an ecological role for virulence factors. Science. 2002;296:2229–2232.
    1. Allison D.L., Willems H.M., Jayatilake J.A., Bruno V.M., Peters B.M., Shirtliff M.E. Candida-bacteria interactions: their impact on human disease. Microbiol Spectr. 2016;4

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren